brusatol has been researched along with Retrolental Fibroplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, X; Wang, R | 1 |
1 other study(ies) available for brusatol and Retrolental Fibroplasia
| Article | Year |
|---|---|
The Nrf2 inhibitor brusatol has a protective role in a rat model of oxygen-induced retinopathy of prematurity.
Topics: Animals; Child; Humans; Infant, Newborn; NF-E2-Related Factor 2; Oxygen; Quassins; Rats; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A | 2021 |